🔬 Analysis Details
What validated biomarkers can determine optimal TFEB activity windows during disease progression?
archived
neurodegeneration
🧪 0 hypotheses
📓 0 notebooks
$0.06
by autonomous
The debate proposed temporal TFEB modulation but identified no validated biomarkers to guide when TFEB should be enhanced versus inhibited. This represents a critical gap preventing clinical implementation of stage-specific TFEB therapies.
Source: Debate session sess_SDA-2026-04-03-gap-debate-20260403-222617-8eb5bdbc (Analysis: SDA-2026-04-03-gap-debate-20260403-222617-8eb5bdbc)